Suboxone Lawsuit Answers About Tooth Decay and Potential Compensation
If you’ve used Suboxone, you probably know it’s meant to help people manage opioid dependence. For some, though, it has caused unexpected dental problems, including tooth decay, gum issues, or even tooth loss. That is what the Suboxone lawsuit is about, with users claiming the medication led to serious dental damage.
At EOL.Law, we help people dealing with dental problems from Suboxone. If your teeth have been affected, we can go over what happened, what it might mean, and what you can do next.
Suboxone Tooth Decay Lawsuit Updates for 2026
The Suboxone tooth decay cases are still moving quickly, and 2026 is shaping up to be an important year for plaintiffs. People are taking on Indivior, the maker of Suboxone, claiming they weren’t warned about serious dental problems that can come from using the sublingual film.
New cases are being filed, court decisions are coming down, and lawyers are making moves to protect their clients’ claims. If you’re following this lawsuit or thinking about whether you might have a claim, staying on top of these updates matters.
Suboxone Lawsuit Updates 2026
- March 11, 2026: Suboxone Dental Injury Litigation Moves Forward
The federal multidistrict litigation over Suboxone dental injuries is progressing. Judge Philip Calabrese in Ohio is overseeing discovery. Plaintiffs and third-party providers must submit medical and pharmacy records showing links between Suboxone use and tooth decay, enamel erosion, and other dental problems. Out of roughly 500 cases, 100 will move to deeper fact-gathering. Fifteen of those may become bellwether trials. Fact sheets and supporting evidence are due April 20, 2026. Defense responses are due by May 20. These bellwether cases will help both sides evaluate the strength of claims and potential settlements.
- March 4, 2026: New Suboxone Tooth Decay Lawsuit Filed by 46 Plaintiffs
A new federal lawsuit brings 46 plaintiffs claiming Suboxone film strips caused tooth decay, enamel damage, and tooth loss. They allege the manufacturers didn’t warn patients or doctors about the dental risks of the dissolvable film. Dental injuries began appearing after the film was introduced, and the FDA later added a warning to the label in June 2022. This case will join the existing multidistrict litigation and may be part of future bellwether trials that help shape settlements.
- March 2, 2026: Suboxone MDL Case Count Update
The Suboxone multidistrict litigation saw a small drop in March, going from 1,853 cases in February to 1,849. There were no new JPML transfer orders, and the docket didn’t show any major developments this month.
- March 1, 2026: New Suboxone Lawsuit Filed
A family from Darrow, Louisiana, filed a lawsuit in the Suboxone MDL, claiming long-term use of Suboxone sublingual film caused permanent dental damage. The plaintiff followed the prescription exactly as directed but was never warned that the acidic film could erode enamel, speed up decay, or cause serious tooth problems. Over time, this led to significant dental deterioration requiring extensive restorative work. The lawsuit argues that timely warnings or safer alternatives could have prevented the damage.
- February 25, 2026: 100 Plaintiffs Enter Core Discovery Pool
Judge Calabrese selected 100 plaintiffs in the Suboxone Film MDL for the Core Discovery Pool under Case Management Order No. 15. These cases were chosen because defendants have mostly completed collecting records. Being in the pool doesn’t mean a trial is set, but it puts cases into a smaller group for more detailed discovery. This step helps the court test cases and move closer to potential bellwether trials and settlement discussions.
- January 18, 2026: Suboxone Lawsuit Court Conference
A case-management conference is scheduled for January 21, 2026, where the judge and lawyers will review progress in the Suboxone lawsuit. They will discuss updates on medical records and other documents from outside companies, as well as any missing or incomplete information from plaintiffs and defendants. The court will also address document disputes, confidentiality issues, and set next steps for the litigation. Finally, the location for the next conference on February 25 will be confirmed.
- January 14, 2026: Suboxone Settlement Update
Many people affected by dental injuries from Suboxone are eager to know when settlement payouts might start. While early settlements are possible, they’re unlikely. Cases usually gain momentum when bellwether trials approach, putting pressure on Indivior. With key trials scheduled for 2026, that is when serious settlement discussions are expected to ramp up.
- January 7, 2026: MDL Adds 33 Cases, Document Issues Addressed
The judge held a Zoom status conference to discuss missing documents and problems with evidence collection in the Suboxone MDL. Parties were ordered to identify any remaining portions of the Suboxone tablet non-disclosure agreement and submit the list by January 12. A representative from the document storage company must appear at the next hearing to explain missing materials, and the court asked for updates on scanning errors and depositions. Both sides were also instructed to continue coordinating on which plaintiffs have completed record collection, so cases can move forward.
- January 6, 2026: Suboxone MDL Reaches 1,907 Cases
As of January 2026, the Suboxone tooth decay MDL has 1,854 pending cases and 1,907 total cases overall.
Suboxone Lawsuit Updates 2025
- December 9, 2025: MDL Adds 33 Cases, Documents Reviewed
The court held a Zoom status conference to address missing documents, scanning errors, and progress in collecting evidence for the Suboxone MDL. Parties were ordered to list any remaining parts of the Suboxone tablet non-disclosure agreement and submit it by January 12, 2026. A representative from the document storage company must attend the January 21 hearing to explain missing materials. The judge also asked for updates on depositions, coordination on completed records, and responses to requests limiting public access to portions of a prior transcript.
- September 28, 2025: Plaintiffs Respond to Show Cause Orders
Over the past two weeks, 132 plaintiffs in the Suboxone Film MDL filed responses to show cause orders. These filings explain why their claims should not be dismissed for missing census forms or other procedural gaps. Cases that fail to respond may be dismissed, while the recent wave shows a coordinated effort to keep active claims on the docket.
- September 18, 2025: Court Cracks Down on Procedural Compliance
Judge Calabrese issued a new order tightening enforcement in the Suboxone tooth decay litigation. The court required three remaining third-party providers to turn over necessary records and warned of contempt motions if they fail to comply. Claims from plaintiffs who didn’t meet prior deadlines were permanently dismissed. The court also signaled that procedures for Census Round 2 will be issued to gather information needed for potential settlements.
- September 9, 2025: Suboxone Status Conference
Today’s hearing focuses on keeping the Suboxone cases moving. The judge will check on subpoenas to treatment centers and a pharmacy that haven’t turned over records. Cases with missing census or medical forms may be dismissed. Updates will also be provided on the “Record Collection Pool” cases and on deadlines for document production and corporate witness testimony.
- September 5, 2025: Suboxone MDL Case Count
As of early September, 1,882 filings are pending in the Suboxone tooth decay MDL in Ohio. Batch filings of up to 100 plaintiffs per complaint mean the docket underrepresents the number of individuals pursuing claims. Estimates suggest more than 20,000 people are involved. It remains unclear how many of these claims will be compensable, though likely less than half.
- August 27, 2025: Suboxone MDL Show-Cause Hearing
Judge Calabrese held a brief hearing to address four providers who have not produced required records. Plaintiffs’ lawyers detailed months of attempts to obtain the records and asked for fees, expenses, and possible sanctions. No representatives from the noncompliant providers appeared, and the judge is reviewing the matter. Without these records, prescription histories can’t be verified, and cases remain stalled, but the court’s willingness to enforce sanctions shows pressure is building to keep the MDL moving toward bellwether trials and settlements.
- August 18, 2025: Batch Filing of Suboxone Lawsuits
A new lawsuit includes 54 plaintiffs from across the U.S., claiming serious dental injuries from Suboxone film. Each plaintiff used the drug as prescribed and later suffered tooth decay, enamel erosion, or tooth loss. They allege the manufacturers knew the film was acidic and harmful but failed to provide adequate warnings until the FDA required one in June 2022. The case reflects the trend of larger batch filings with many plaintiffs pursuing claims together in the MDL.
- August 10, 2025: Records Bottleneck Continues
Collecting medical and pharmacy records remains a major hurdle in the Suboxone MDL. Many record-holders have been slow or noncompliant, stalling cases and delaying evidence of prescription histories. Judge Calabrese issued a show-cause order for nearly twenty noncompliant pharmacies to appear in court and explain delays. Resolving this bottleneck is critical for moving toward bellwether trials and eventual settlements.
- July 17, 2025: Why Indivior Might Be Underestimating Settlement Risk
Indivior may be assuming juries will not connect with people in recovery, but plaintiffs are real people, including parents, workers, and spouses, who followed their treatment plans and trusted the system. Instead of support, they faced permanent dental damage, chronic pain, and tens of thousands of dollars in dental bills. Juries are likely to see the human cost and understand that Indivior put profits first. Misjudging this could cost the company far more than a fair settlement.
- July 11, 2025: Suboxone Lawsuit Profile Is Changing
Suboxone cases are gaining attention as plaintiffs’ stories emerge. Many people in recovery, with no prior dental problems, now face tens of thousands in dental reconstruction costs. Media coverage or trial exhibits could quickly bring the cases into the public eye. A high-profile verdict could significantly change Indivior’s risk assessment.
- July 8, 2025: Deposition Process Updated
The MDL judge issued a new order on depositions for general and bellwether witnesses. Most depositions will be in person unless both sides agree to do them remotely. Strict rules cover confidentiality and handling of documents. Lawyers must provide exhibits in advance, confirm that sealed documents are protected, and coordinate scheduling. These procedures help keep discovery organized and prepare the case for trial efficiently.
- July 3, 2025: Misreading Juries: Indivior’s Flawed Assumptions
Indivior may believe juries will not sympathize with plaintiffs in recovery, but real people, including teachers, nurses, and warehouse workers, are facing full dentures, massive dental bills, and emotional distress. Their stories resonate in court and overcome stigma, especially given the company’s previous felony marketing convictions. Plaintiffs’ lawyers are ready to show the human cost, and if settlements fail, juries may award damages that reflect the true impact.
- June 27, 2025: Challenges in Getting Pharmacy Records
Obtaining pharmacy records has been a major hurdle in the Suboxone litigation. Walgreens, Safeway, and Porch Light Health were ordered to explain why they had not complied with record requests. Two providers were later cleared, but Walgreens still faces a show-cause hearing scheduled for Friday. Without these records, it is difficult for plaintiffs to prove prescription histories and move their cases forward.
- May 24, 2025: Preparing for Bellwether Trials
The MDL judge issued an amended case management order outlining the process for bellwether trials. Plaintiffs start in a 500-member Records Collection Pool, providing medical authorizations and documentation. From there, 100 cases move into the Core Discovery Pool, and eventually 15 are selected for the Trial Pool, leading to four potential bellwether trials. This structured roadmap helps guide the first trials if a global Suboxone settlement does not happen first.
- March 13, 2025: Schedule A Claims Shrink
After the Suboxone MDL was created, a looming two-year statute of limitations pushed many plaintiffs to file quickly. Judge Calabrese allowed a consolidated “Schedule A” case covering about 9,600 people to keep filings manageable and reduce costs. Most claims were still gathering documentation, and some later proved unviable, bringing the total down to 8,611. A new order is expected soon to address the next statute of limitations deadline and prevent a repeat of this filing rush.
Suboxone Lawsuit Updates 2024
- November 23, 2024: Managing Multiple Lawyers for Suboxone Claims
Many Suboxone victims have hired more than one lawyer, which can slow cases and complicate settlements. At a recent status conference, the court emphasized that attorneys need to use the Rubris Crosslink platform to address duplicate representation. This system tracks clients across participating firms and flags when someone has retained multiple lawyers. By resolving these conflicts early, cases can move more smoothly and efficiently for everyone involved.
- September 23, 2024: Why Suboxone Cases Focus on Brand-Name Users
Most Suboxone lawsuits target people who used the brand-name drug before June 2018, when Indivior controlled the market. After that, generics took over, but suing them is much more complicated. Courts generally protect generic manufacturers from failure-to-warn claims because they must copy the brand name label exactly. This means plaintiffs usually focus on Indivior, even if they were harmed while taking a generic version.
- July 2, 2024 – Suboxone Settlement Rumors
There has been occasional speculation about early settlements in the Suboxone MDL. While the idea circulates, it is unlikely that Indivior will engage in serious settlement discussions before June 2026.
- May 17, 2024: Managing Statute of Limitations with a Tolling Period
Plaintiffs’ lawyers requested a tolling period so clients could preserve their Suboxone claims without rushing to file lawsuits. Many states have a two-year statute of limitations, with a potential bar date around June 17, 2024. The court set a compromise: by June 14, 2024, a master MDL complaint must be filed listing individual plaintiffs on a Schedule A. Defendants may then request severance by July 1, 2024, with severed claims continuing as individual actions while keeping their original filing dates intact. This approach helps manage many claims efficiently without overwhelming the court system.
- February 4, 2024: Suboxone MDL Established
The Judicial Panel on Multidistrict Litigation has consolidated federal Suboxone lawsuits into a single MDL. These cases allege that Suboxone film manufacturers did not properly warn patients about potential dental damage. Fifteen lawsuits from five districts were moved to the U.S. District Court for the Northern District of Ohio, with Judge J. Philip Calabrese overseeing the proceedings. The case is officially titled In re: Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation, MDL No. 1:24-md-03092.
- January 30, 2024: Statute of Limitations Concerns for Suboxone Claims
Some potential Suboxone plaintiffs face tight deadlines due to state statutes of limitations, especially in states with a two-year window. Lawyers are cautious about taking cases in these jurisdictions, particularly if the injuries are recent or the product warning was unclear. There is a legal argument that the clock may not have started because the label did not adequately warn about dental risks. Currently, new cases are being accepted in select states including Texas, Florida, New York, North Carolina, and many others across the country.
- January 22, 2024: New Suboxone Case Tests Statute of Limitations
A recent Suboxone lawsuit in Kentucky highlights challenges with filing after the statute of limitations may have passed. The plaintiff, a resident of Mt. Sterling, alleges that long-term use of Suboxone film caused tooth decay, which he only discovered in late 2023. Kentucky has a strict one-year filing window, but the plaintiff is relying on the discovery rule, arguing that the clock started when he became aware of his dental injuries. This case could set an important precedent for other late-discovery Suboxone claims.
Suboxone Lawsuit Updates 2023
- December 13, 2023: Defendants Back Proposal to Consolidate Suboxone Cases into MDL
The defendants in the Suboxone tooth decay lawsuits recently responded to the request for class action multidistrict litigation (MDL) consolidation. Surprisingly, they agreed to the motion, suggesting the creation of a new Suboxone class action MDL. They propose assigning the MDL to Judge Philip Calabrese in the Northern District of Ohio, with the likely establishment next month.
- December 7, 2023: Video Update: Why an MDL Could Boost Suboxone Settlements
A new video provides the latest updates on efforts to initiate a Suboxone class action lawsuit, emphasizing how an MDL can exert significant settlement pressure on Indivior. Our legal experts also discuss the main reasons they believe most victims bringing a Suboxone lawsuit will have a strong case.
- November 27, 2023: Plaintiffs Push to Combine Federal Suboxone Cases in One MDL
Plaintiffs’ legal representatives have petitioned the U.S. Judicial Panel on Multidistrict Litigation to consolidate all federal lawsuits related to Suboxone into a single MDL for streamlined pretrial proceedings. This move could be a game-changer, efficiently managing claims spread across multiple districts nationwide in a potential Suboxone class action lawsuit.
- November 3, 2023: 14 New Suboxone Lawsuits Filed, Ohio Leading the Way
Within the last two weeks, 14 new Suboxone product liability lawsuits have been filed in federal courts against the manufacturer, Indivior. Notably, eight of these were filed in the Northern District of Ohio, which currently holds the most pending Suboxone cases of any district.
- October 30, 2023: Indivior Faces Tooth Decay Suits and Federal Kickback Case
Indivior, the manufacturer of Suboxone, is facing a dual legal battle. As tooth decay Suboxone lawsuits continue to rise, Indivior is also defending a False Claims Act lawsuit, accusing the company of an illegal kickback scheme. A federal judge rejected Indivior’s motion to dismiss the case, allowing it to move forward.
- October 24, 2023: Indivior Settles Antitrust Claims Over Suboxone Film Strategy
Indivior, the maker of Suboxone, has agreed to pay an additional $385 million to settle an antitrust lawsuit, alleging the illegal suppression of generic competition. Claims suggest Indivior introduced a dissolving film tab version of Suboxone to block competition from generic Suboxone tablets, paying a total of $1.3 billion to settle similar lawsuits.
- October 16, 2023: Ohio Man Files Suboxone Tooth Decay Lawsuit After 16 Months
In a new Suboxone tooth decay lawsuit, a man from Geauga County, Ohio, became the latest plaintiff, alleging severe tooth decay after just 16 months on Suboxone. The complaint highlights the lack of awareness about Suboxone causing tooth decay, both for the plaintiff and his doctor.
How Does Suboxone Work in Treating Opioid Addiction?
Suboxone is a medication crafted to offer understanding and support for those battling opioid addiction. It serves as a valuable tool for doctors striving to guide patients away from opioids. Administered through sublingual films or tablets, Suboxone plays a key role in a thoughtful treatment plan that includes counseling and therapy.
Suboxone combines two active ingredients: buprenorphine and naloxone. Buprenorphine, a partial opioid agonist, gently activates brain receptors associated with opioids, easing withdrawal symptoms and cravings without the overwhelming high. Naloxone, an opioid antagonist, reverses opioid effects, potentially leading to withdrawal if misused.
Originally developed by Reckitt Benckiser, Suboxone gained approval from the United States Food and Drug Administration in 2002. Buprenorphine, approved the same year, is administered underneath the tongue to treat opioid use disorder.
What Are the Concerns About Suboxone's Effects on Dental Health?
Just like any medication, Suboxone has potential side effects that warrant attention. Studies indicate that sublingual films, which dissolve under the tongue, may contribute to tooth decay and other dental issues due to their acidic nature. Prolonged exposure to this acidity can weaken tooth enamel, leading to painful problems that might require dental procedures like extractions, fillings, or implants. Medical literature has reported cases of tooth decay associated with Suboxone use since 2012. Additionally, the FDA has noted hundreds of adverse events related to tooth decay annually, with 40% of these incidents classified as serious.
Potential dental issues with Suboxone include:
- Cavities
- Cracked teeth
- Crown or crown replacement
- Dental caries (loss of enamel, dentine, etc.)
- Gum injuries
- Infections
- Oral surgeries, like tooth extraction
- Root canal
- Tongue injuries
- Tooth decay
- Tooth fractures
- Tooth loss
What Are the Signs of Tooth Decay from Suboxone Use?
Understanding signs of tooth decay from Suboxone use means keeping an eye out for the following:
- Cavities and oral infections. Suboxone use may contribute to tooth decay and cavities. Reduced saliva flow and potential lapses in dental hygiene can lead to cavities and oral infections.
- Dry mouth. Suboxone can decrease saliva production, resulting in a dry mouth. This dry environment increases the risk of decay as lingering food particles create a breeding ground for bacteria.
- Sore or fragile teeth. Some may experience immediate soreness or fragility in their teeth. In severe cases, teeth may feel loose or become wobbly.
- Tooth loss. Tooth decay linked to Suboxone use could, in some instances, progress to tooth loss.
How to Deal with Dental Issues from Suboxone Use
Here’s how to approach dental problems caused by Suboxone use:
- Communication is key. Make sure to share your Suboxone use with both your doctor and dentist. This helps in creating a comprehensive plan to manage potential dental issues promptly.
- Post-procedure pain management. If you need a dental procedure while on Suboxone, work closely with healthcare professionals to develop a plan for managing any pain afterward. This might involve using non-opioid pain relievers or other effective strategies.
- Prioritize oral hygiene. Good oral hygiene is crucial. Stick to regular brushing and flossing to prevent tooth decay and other dental problems associated with Suboxone use.
- Regular checkups matter. Schedule and attend regular dental checkups. This ensures early detection and proper management of any dental problems that may arise from Suboxone use.
What Are the Suboxone Lawsuits About?
More and more individuals are filing Suboxone lawsuits nationwide. These lawsuits claim the manufacturers behaved wrongly and negligently in various aspects of the product’s development, design, testing, labeling, packaging, promotion, advertising, marketing, distribution, and sale. They specifically argue the manufacturers either knew or should have known that using Suboxone as prescribed could harm teeth due to the acidity of buprenorphine. Despite this knowledge, the plaintiffs assert the manufacturers sold and marketed Suboxone without initially warning about the risks of tooth decay. The plaintiffs are seeking compensation for the costs of dental repairs and treatment.
In January 2022, the FDA issued a public communication warning about tooth decay risks linked to Suboxone. It was only after this FDA warning that the Suboxone makers updated the drug’s warning label to include information about the risk of tooth decay. This situation is seen as a clear example of negligent failure to warn, making the manufacturers potentially liable.
Who Are the Key Defendants in Suboxone Lawsuits?
The main defendants in lawsuits related to Suboxone tooth decay are Indivior, Inc. and its parent company, Reckitt Benckiser. Indivior is responsible for developing and selling Suboxone, a medication used for treating opioid addiction. Although initially part of Reckitt, Indivior became an independent publicly traded company in 2014, focusing specifically on opioid dependency treatment.
The lawsuits against Indivior, Reckitt, and their US affiliates claim that they failed to adequately warn about Suboxone’s risks, including tooth decay, cavities, and dental issues. Furthermore, as highlighted in the final Suboxone monopoly lawsuits, the company was found to be unlawfully suppressing generic competition.
While various companies related to Suboxone are generally involved in these legal actions, Indivior is expected to bear primary responsibility. It’s worth noting that Indivior has faced legal issues with US authorities, with the Department of Justice recently indicting the company for participating in an illegal scheme to direct patients to specific doctors prescribing Suboxone and other Indivior drugs. This matter was resolved with Indivior agreeing to pay $102 million in damages to 42 different states.
What Are Legal Issues in Suboxone Lawsuits?
In Suboxone lawsuits, people typically bring forth various legal claims based on the harm they’ve experienced due to Suboxone use. Here are common legal claims seen in Suboxone lawsuits:
Breach of Warranty:
- Express warranty. Stating the manufacturer made promises about Suboxone’s safety or effectiveness that were not fulfilled.
- Implied warranty. Asserting that Suboxone didn’t meet expected standards for quality or specific purposes.
Fraud and Misrepresentation:
- Concealment of information. Accusing the manufacturer of hiding crucial details about Suboxone’s risks.
- False advertising. Claiming that Suboxone’s advertising contained false or misleading information.
Medical Malpractice:
- Inadequate monitoring or treatment. Holding healthcare providers accountable if they didn’t properly monitor or treat Suboxone users, leading to harm.
Negligence:
- Negligent manufacturing. Claiming Suboxone’s manufacturing process was conducted carelessly, resulting in harm.
- Negligent marketing. Alleging the pharmaceutical company engaged in misleading marketing practices for Suboxone.
Product Liability:
- Defective design. Stating that Suboxone had a design flaw making it unreasonably dangerous.
- Failure to warn. Accusing the manufacturer of not adequately warning about potential risks and side effects of Suboxone.
- Manufacturing defect. Alleging the manufacturing process resulted in a defect in the specific Suboxone product consumed.
Wrongful Death:
- Loss of life. In cases where Suboxone use is alleged to have caused an individual’s death.
The specific claims in a Suboxone lawsuit can vary based on each case’s details. Those pursuing legal action can consult with pharmaceutical litigation attorneys to determine the most applicable claims for their situation. Additionally, the legal landscape may evolve, leading to new claims based on emerging evidence or changes in regulations.
What Is the Current Status of the Suboxone Tooth Decay Lawsuit?
As of October 2023, the Suboxone tooth decay lawsuit is in the early stages. Suboxone lawyers are actively reviewing potential cases, and the legal process is just beginning. Notably, there haven’t been any settlements or trials specifically addressing dental issues so far. However, it’s worth mentioning that Indivior, in separate cases, has already settled for $385 million to settle lawsuits in the U.S. brought by drug wholesalers on claims it illegally suppressed generic competition for its opioid addiction treatment Suboxone, although not related to dental concerns. The situation is dynamic, and updates may occur as the legal proceedings progress.
Is There a Suboxone Class Action Lawsuit?
Numerous individual Suboxone lawsuits are currently in progress, involving drug manufacturers or medical providers. Additionally, there is an MDL (multi-district litigation), akin to a class action. Due to the substantial volume of cases related to Suboxone side effects, the MDL consolidates all federal cases to streamline pretrial proceedings. While not formally categorized as a buprenorphine class action lawsuit, the MDL provides a platform for numerous plaintiffs with similar allegations against the defendants to collaborate effectively.
Who Qualifies for a Suboxone Lawsuit?
Individuals who used sublingual films and experienced dental problems may be eligible to file a Suboxone lawsuit. These dental issues include:
- Broken teeth
- Jawbone deterioration
- Other significant tooth problems
- Required dental implants
- Severe tooth decay
- Tooth extractions
- Tooth loss
- Underwent oral surgery
What Previous Legal Actions Have Targeted Indivior and Reckitt Benckiser?
Indivior aimed to protect the patent protection of Suboxone, maintaining exclusive rights to manufacture and sell the drug. To sustain its monopoly, the company altered the dosage form.
In 2016, the Department of Justice sued Reckitt Benckiser for violating the Sherman Act, prohibiting monopolistic practices. The lawsuit concluded with a $102.5 million Suboxone settlement involving Indivior.
On April 9, 2019, a Virginia federal grand jury indicted Indivior for orchestrating a national scheme to unlawfully boost Suboxone sales. This legal action resulted in Reckitt Benckiser paying over $1.4 billion to the federal government, various states, and the Federal Trade Commission.
By October 2023, Indivior reported settling for $385 million with several states, insurance companies, and other direct purchasers to address specific antitrust and class action claims.
The MDL trial, initially scheduled for October 30, has been postponed as the Court reviews the proposed settlement.
Why Are Individuals Filing Suboxone Lawsuits?
People who have encountered tooth decay, cavities, or tooth loss due to Suboxone usage may qualify for a Suboxone tooth decay lawsuit. Certain individuals had to undergo procedures like crowns, implants, or dentures to address the harm, alleging that the drug manufacturers did not adequately warn them about potential risks to their teeth.
What Are Your Legal Rights and Options for Compensation?
If you or a loved one has faced adverse effects from Suboxone, understanding your legal rights is crucial. You have the right to seek compensation for the damages endured. The amount of compensation in Suboxone lawsuits can vary, depending on factors like the severity of harm, specific legal claims, and individual circumstances. Compensation may cover:
- Legal fees and costs. Prevailing parties may be awarded reimbursement for attorney’s fees and other legal costs.
- Lost income. Compensation for income lost due to Suboxone-related harm, including past and future lost wages.
- Medical expenses. Reimbursement for past and future medical costs related to Suboxone-induced injuries.
- Pain and suffering. Non-economic damages for emotional distress, loss of enjoyment of life, and physical pain.
- Punitive damages. Awarded in egregious cases to punish and deter similar conduct.
- Wrongful death damages. In cases of death due to Suboxone use, compensation may include funeral expenses, loss of companionship, and related damages.
Taking legal action can offer support and hold responsible parties accountable. Lawsuit outcomes vary, and not all individuals receive the same compensation. Suboxone settlements, common in pharmaceutical litigation, may also impact the final amount. Consulting experienced attorneys specializing in pharmaceutical litigation is advisable for a case evaluation and potential compensation estimate.
Can I Still Apply for Suboxone Lawsuit?
The answer is yes. It’s still possible to join a Suboxone lawsuit as of March 2026, but it depends on your state’s deadlines and your personal situation. This is especially relevant if you’ve experienced Suboxone lawsuit teeth issues, like tooth decay or other dental problems linked to the medication.
To qualify, you generally need:
- A valid Suboxone prescription from before June 2022
- At least six months of Suboxone use
- Dental issues linked to the medication, like tooth decay, gum disease, tooth loss, or other oral problems
Deadlines vary by state, usually 1–3 years from when you noticed the injury, though some states allow up to six years. In the MDL, Fact Sheets must be submitted by April 20, 2026.
Reach out to EOL.Law as soon as you can. We’ll review your case, make sure you meet the deadlines, and help collect your medical and dental records. Waiting too long could mean missing your chance.
How to Pursue a Suboxone Dental Lawsuit
If you suspect Suboxone caused your tooth decay and are contemplating legal action, follow this simplified guide:
- Visit a dentist. Have your tooth decay assessed and documented by a dentist; this evidence is vital for your case.
- Gather records. Collect all relevant medical and dental records detailing Suboxone use and the onset of tooth decay.
- Find an attorney. Seek an experienced pharmaceutical attorney to understand your options and navigate the legal process.
- Share information. Inform your attorney about your medical history, Suboxone use, tooth decay, and any communication with healthcare professionals.
- Identify damages. Collaborate with your attorney to list damages, including medical expenses, ongoing treatments, and pain and suffering.
- Build your case. Your attorney will investigate, review records, and gather evidence to strengthen your case.
- Determine legal claims. Work with your attorney to identify legal claims against the Suboxone manufacturer, such as failure to warn or negligence.
- Negotiate or sue. Your attorney may negotiate for a settlement; if not, they might advise filing a lawsuit.
- Legal process. If your case proceeds to court, your attorney will guide you through steps like discovery and, if necessary, trial.
- Potential compensation. If successful, you may receive compensation for medical expenses, pain, suffering, and other damages determined by the court.
Every case is unique, and seeking advice from a qualified Suboxone dental lawsuit attorney is crucial for personalized guidance.
What Are the Potential Suboxone Settlement Amounts?
As of March 2026, there haven’t been any settlements specifically for Suboxone tooth decay cases. That means any numbers you hear are just estimates based on the ongoing MDL No. 3097 in Ohio’s Northern District Court. Lawyers at EOL.Law say potential settlements could range from $50,000 to $150,000 per case, depending on how severe the dental injuries are, how long Suboxone was used, the cost of dental treatment, and the strength of your evidence. Less serious cases may settle for lower amounts, while severe cases could go higher.
If a case goes to trial past the bellwether stage, verdicts could top $1 million, including punitive damages. Most cases, however, are likely to settle before trial. With about 1,900–2,000 cases currently in discovery, and statutes of limitations varying by state (1–6 years from when the injury was discovered), timing and eligibility play a big role in what someone might recover.
Anyone dealing with dental problems from Suboxone should reach out to a Suboxone teeth lawsuit attorney at EOL.Law as soon as possible. Acting early helps make sure your claim is preserved and your records are in order, so you’re ready when the bellwether trials set the stage for potential settlements later in 2026.
What Settlements Have Been Reached in Suboxone Teeth Lawsuits?
As of March 2026, no settlements have been reached specifically for Suboxone-related tooth decay cases.
There have been other Suboxone-related settlements, though not tied to dental injuries:
- In May 2021, the Federal Trade Commission resolved false marketing claims related to Suboxone with a $60 million agreement.
- In August 2023, Indivior settled for $30 million with healthcare plans that had filed a lawsuit against the company.
- In October 2023, Indivior agreed to pay $385 million to settle monopoly lawsuits by drug wholesalers, alleging the illegal suppression of generic competition for Suboxone.
If you’ve experienced dental injuries due to Suboxone use, you may be eligible for compensation through future Suboxone teeth lawsuit payout. Consult with EOL.Law to assess your case and determine the best course of action.
Choosing EOL.Law
Navigating a Suboxone lawsuit can be a challenging journey, but understanding your rights and having the right legal support can make all the difference. If you or a loved one has faced dental issues or other complications linked to Suboxone use, remember that seeking justice is your right. At every step, your voice matters, and at EOL.Law, we’re here to ensure it’s heard. Don’t hesitate to reach out. We specialize in personal injury cases, including those related to Suboxone. Your path to justice begins with a conversation. Contact us today for a free consultation.
Frequently Asked Questions
What is the problem with Suboxone?
Suboxone is a medicine used to treat opioid addiction and helps reduce cravings and withdrawal. While it is effective, some people experience side effects like nausea, dizziness, constipation, or dry mouth. The bigger concern in recent years is tooth damage linked to the dissolvable film form. Lawsuits claim the manufacturer didn’t warn patients or doctors about the risk of rapid tooth decay.
Does Suboxone cause catastrophic dental decay?
Not everyone who takes Suboxone will have serious dental problems, but the film form can sometimes cause rapid decay and tooth loss. The strip is acidic and can weaken enamel if held in the mouth for long periods. Dry mouth caused by the medicine also increases cavity risk. The FDA and many lawsuits warn about these potential severe dental issues.
How do I file a Suboxone lawsuit for tooth decay?
You usually file through a product‑liability attorney, often as part of a federal multidistrict litigation (MDL 3092) in Ohio. First, your attorney will check if your dental damage and Suboxone use meet the MDL criteria. Then they will gather your dental and prescription records and file your claim in the MDL court. The attorney handles all paperwork and ensures your case is part of the ongoing litigation.
How much is the Suboxone lawsuit payout per person?
There is no guaranteed payout, and amounts vary by case. Estimates suggest most individual settlements fall between $25,000 and $150,000, with severe cases potentially higher. The total depends on how many teeth were affected, treatment costs, and impact on your life. Attorney fees are usually taken from the settlement, so you won’t receive the full amount listed in projections.
What disqualifies you from the Suboxone lawsuit?
Cases are usually rejected if you didn’t take the Suboxone film or have only minor dental issues. Missing dental or prescription records can weaken your claim. Using Suboxone for a very short time or having pre-existing severe dental problems may also disqualify you. Additionally, waiting too long after noticing dental damage could prevent filing because of statute-of-limitations rules.
